ACS Medicinal Chemistry Letters · 2020 · 17 citations · 22 references
PharmacyMedicinal ChemistryMolecular BiologyComputational BiologyDrug DesignDrug DiscoveryComputational Drug DiscoveryComputational Drug RepurposingDrug Repurposing InformaticsStructure-based RepurposingTyrosine Kinase InhibitorsChemoinformatics-based RepurposingComputational Drug Repurposing ResourcesCyclin-dependent Kinase InhibitorsKinase Inhibitor Library DesignMethyl Group ReplacementOpen-source Software DevelopmentSelective Tyrosine Kinase InhibitorsTyrosine Kinase Inhibition
, a highly selective DYRK1A inhibitor.
22
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis, Jeremy P. Hunt, Sanna Herrgård et al. · Nature Biotechnology · 2011 · 2.4K citations · Full text
The ChEMBL bioactivity database: an update
A. Patrícia Bento, Anna Gaulton, Anne Hersey et al. · Nucleic Acids Research · 2013 · 1.5K citations · Full text
KNIME - the Konstanz information miner
Michael R. Berthold, Nicolas Cebron, Fabian Dill et al. · ACM SIGKDD Explorations Newsletter · 2009 · 1.2K citations · Full text
Travis T. Wager, Xinjun Hou, Patrick R. Verhoest et al. · ACS Chemical Neuroscience · 2010 · 1K citations